首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >The Therapy of Elimination First for Early Acute Mastitis: A Systematic Review and Meta-Analysis
【2h】

The Therapy of Elimination First for Early Acute Mastitis: A Systematic Review and Meta-Analysis

机译:早期急性乳腺炎的消除疗法为先:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We evaluated the effectiveness of “the therapy of elimination first” in early acute mastitis, using four databases (CNKI, Wanfang, Embase, and PubMed). The study incorporated 2508 patients from 16 randomized controlled trials (RCTs). Included trials used Chinese oral medicine and applied the principle of “Eliminating Therapy” for the early treatment of acute mastitis, with simple antibiotic treatment as a control group. Meta-analysis showed significant differences between the overall effectiveness of oral Chinese medicine using Eliminating Therapy (OCM-ET) and western medicine using antibiotics (WM-A) (odds ratio [OR] = 4.43, 95% confidence interval [CI] = 3.21–6.12, Z = 9.04, and P < 0.00001). Analysis of subgroups based on the use of classic or self-made preparations of the medicines showed smaller statistical heterogeneity among the different subgroups (P > 0.05, I2 ≤ 50%). The OCM-ET group showed significantly shorter pain relief times [mean difference (MD) = −3.08, 95% CI = (−5.90, −0.26), and P = 0.03] and cure times [MD = −6.27, 95% CI = (−9.68, −2.85), and P = 0.0003] than did the WM-A group. Our findings suggest that OCM-ET can shorten the duration of pain and improve cure time in early acute mastitis patients, with fewer adverse reactions. However, RCTs of higher quality with larger sample sizes are required to confirm these findings.
机译:我们使用四个数据库(CNKI,Wanfang,Embase和PubMed)评估了“早期消灭治疗”在早期急性乳腺炎中的有效性。该研究纳入了来自16个随机对照试验(RCT)的2508名患者。纳入的试验使用中药口服药,并以“消灭疗法”的原则用于急性乳腺炎的早期治疗,以简单的抗生素治疗为对照组。荟萃分析显示,使用消除疗法的口服中药(OCM-ET)和使用抗生素的西药(WM-A)的整体有效性之间存在显着差异(赔率[OR] = 4.43,95%置信区间[CI] = 3.21) –6.12,Z = 9.04,且P <0.00001)。使用经典或自制药物进行的亚组分析显示,不同亚组之间的统计异质性较小(P> 0.05,I2≤50%)。 OCM-ET组显示出明显更短的止痛时间[平均差异(MD)= -3.08,95%CI =(−5.90,-0.26),P = 0.03]和治愈时间[MD = -6.27,95%CI =(-9.68,-2.85),并且P = 0.0003]。我们的发现表明,OCM-ET可以缩短早期急性乳腺炎患者的疼痛持续时间并改善治愈时间,且不良反应较少。但是,需要更高质量的RCT和更大的样本量来确认这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号